These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16809632)

  • 1. Predicting non-completion of treatment for latent tuberculous infection: a prospective survey.
    Shieh FK; Snyder G; Horsburgh CR; Bernardo J; Murphy C; Saukkonen JJ
    Am J Respir Crit Care Med; 2006 Sep; 174(6):717-21. PubMed ID: 16809632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of TB in inmates with latent TB infection: 5-year follow-up.
    White MC; Tulsky JP; Menendez E; Goldenson J; Kawamura LM
    Am J Prev Med; 2005 Nov; 29(4):295-301. PubMed ID: 16242592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
    Hoopes AJ; Kammerer JS; Harrington TA; Ijaz K; Armstrong LR
    Arch Intern Med; 2008 Oct; 168(18):1984-92. PubMed ID: 18852399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for failure to complete a course of latent tuberculosis infection treatment in Salvador, Brazil.
    Machado A; Finkmoore B; Emodi K; Takenami I; Barbosa T; Tavares M; Reis MG; Arruda S; Riley LW
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):719-25. PubMed ID: 19460247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City.
    Li J; Munsiff SS; Tarantino T; Dorsinville M
    Int J Infect Dis; 2010 Apr; 14(4):e292-7. PubMed ID: 19656705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin.
    Lardizabal A; Passannante M; Kojakali F; Hayden C; Reichman LB
    Chest; 2006 Dec; 130(6):1712-7. PubMed ID: 17166986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study.
    Schein YL; Madebo T; Andersen HE; Arnesen TM; Dyrhol-Riise AM; Tveiten H; White RA; Winje BA
    BMC Infect Dis; 2018 Nov; 18(1):587. PubMed ID: 30453946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of smoking on adherence to treatment for latent tuberculosis infection.
    Lavigne M; Rocher I; Steensma C; Brassard P
    BMC Public Health; 2006 Mar; 6():66. PubMed ID: 16536868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment guidelines for latent tuberculosis infection.
    ;
    Kekkaku; 2014 Jan; 89(1):21-37. PubMed ID: 24654427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with failure to complete isoniazid treatment for latent tuberculosis infection in Rhode Island.
    Kwara A; Herold JS; Machan JT; Carter EJ
    Chest; 2008 Apr; 133(4):862-8. PubMed ID: 18071014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of failure to complete treatment for latent tuberculosis infection.
    Parsyan AE; Saukkonen J; Barry MA; Sharnprapai S; Horsburgh CR
    J Infect; 2007 Mar; 54(3):262-6. PubMed ID: 16772095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of prophylaxis on QuantiFERON TB-2G responses among children].
    Higuchi K; Okada K; Harada N; Mori T
    Kekkaku; 2008 Sep; 83(9):603-9. PubMed ID: 18979994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptance of treatment for latent tuberculosis infection: prospective cohort study in the United States and Canada.
    Colson PW; Hirsch-Moverman Y; Bethel J; Vempaty P; Salcedo K; Wall K; Miranda W; Collins S; Horsburgh CR;
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):473-9. PubMed ID: 23485381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-wide INH treatment of latent TB infection in a BCG-vaccinated population: experience in rural Taiwan.
    Bowerman RJ
    Int J Tuberc Lung Dis; 2007 Apr; 11(4):470-2. PubMed ID: 17394696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment.
    Trajman A; Long R; Zylberberg D; Dion MJ; Al-Otaibi B; Menzies D
    Int J Tuberc Lung Dis; 2010 May; 14(5):551-9. PubMed ID: 20392347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting completion of treatment among foreign-born adolescents treated for latent tuberculosis infection in Los Angeles.
    Coly A; Morisky D
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):703-10. PubMed ID: 15182139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of pediatric latent tuberculosis infection in a community health center clinic.
    Young J; Edick T; Klee D; O'Connor ME
    Pediatr Infect Dis J; 2012 Sep; 31(9):e147-51. PubMed ID: 22531235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment completion in latent tuberculosis infection at specialist tuberculosis units in Spain.
    Anibarro L; Casas S; Paz-Esquete J; Gonzalez L; Pena A; Guerra MR; Sande D; Calviño L; Santin M;
    Int J Tuberc Lung Dis; 2010 Jun; 14(6):701-7. PubMed ID: 20487607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis prevention for non-US-born pregnant women.
    Sackoff JE; Pfeiffer MR; Driver CR; Streett LS; Munsiff SS; DeHovitz JA
    Am J Obstet Gynecol; 2006 Feb; 194(2):451-6. PubMed ID: 16458645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.